Samsung is proceeding with an investment in Averr BioTechnology (Averr Bio), a U.S.-based biotech company specializing in ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

The long-awaited Gene Technology Bill has stalled because New Zealand First won’t support it as it stands. The sticking point ...

ICHORtec GmbH is pleased to announce an expanded research collaboration with the laboratory of Professor Gregory A. Newby in the Department of Genetic Medicine at the Johns Hopkins University School ...

The government’s long-promised Gene Technology Bill, which aims to reform laws around genetic modification, has run into a ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Gene therapy company Affinia Therapeutics has raised $40m in a Series C funding round, led by New Enterprise Associates (NEA).

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...